- Page Title
- Accelerating AML and MDS Treatment Strategies with Rapid NGS in the myeloMATCH Trial | Thermo Fisher Scientific - US
- Brand
- thermofisher.com
- Type
- Other
- First Seen
- 9/8/2025
- Last Seen
- 9/24/2025
- Domain
- thermofisher.com
- URL
- https://www.thermofisher.com/us/en/home/clinical/preclinical-companion-diagnostic-development/oncomine-oncology/ngs-hemato-oncology/rapid-ngs-myelomatch-trial.html?cid=csd_cdx_sbu_r01_co_pfo-1002_pgm-1915_col000000_0so_fbk_da_awa_at_s23_Radich-Custom-Audi
- Description
- Rapid NGS testing has recently been implemented as part of the myeloMATCH trial, which is the National Cancer Institute's (NCI's) precision medicine umbrella trial for AML and MDS patients.
Getting a full screenshot of this page, this may take a minute…